Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)

Chi Wei Chen; Ming Hsi Wu; Yi Fan Chen; Tsai Yi Yen; Yi Wen Lin; Shu Hsin Chao; Satishkumar Tala; Tung Hu Tsai; Tsann Long Su; Te Chang Lee

doi:10.1016/j.neo.2016.10.005

Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)

Chi Wei Chen, Ming Hsi Wu, Yi Fan Chen, Tsai Yi Yen, Yi Wen Lin, Shu Hsin Chao, Satishkumar Tala, Tung Hu Tsai, Tsann Long Su, Te Chang Lee^*

^*此作品的通信作者

傳統醫藥研究所

研究成果

2 引文斯高帕斯（Scopus）

摘要

The authors regret to have mistakenly placed the figure of body weight change in mice treated with different agents in PC9 cells (Figure 6A, right) with that of PC9/gef B4 cells (Figure 6B, right) during the art work. The corrected Figure 6 was attached below. The authors would like to apologize for any inconvenience caused.

原文	English
頁（從 - 到）	808-809
頁數	2
期刊	Neoplasia
卷	18
發行號	12
DOIs	https://doi.org/10.1016/j.neo.2016.10.005
出版狀態	Published - 2016

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.neo.2016.10.005

其它文件與鏈接

Link to publication in Scopus

引用此

Chen, C. W., Wu, M. H., Chen, Y. F., Yen, T. Y., Lin, Y. W., Chao, S. H., Tala, S., Tsai, T. H., Su, T. L., & Lee, T. C. (2016). Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005). Neoplasia, 18(12), 808-809. https://doi.org/10.1016/j.neo.2016.10.005

@article{1c41a6abd3b048b992d6610ff802fd8d,

title = "Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)",

abstract = "The authors regret to have mistakenly placed the figure of body weight change in mice treated with different agents in PC9 cells (Figure 6A, right) with that of PC9/gef B4 cells (Figure 6B, right) during the art work. The corrected Figure 6 was attached below. The authors would like to apologize for any inconvenience caused.",

author = "Chen, {Chi Wei} and Wu, {Ming Hsi} and Chen, {Yi Fan} and Yen, {Tsai Yi} and Lin, {Yi Wen} and Chao, {Shu Hsin} and Satishkumar Tala and Tsai, {Tung Hu} and Su, {Tsann Long} and Lee, {Te Chang}",

note = "Publisher Copyright: {\textcopyright} 2016 The Authors",

year = "2016",

doi = "10.1016/j.neo.2016.10.005",

language = "English",

volume = "18",

pages = "808--809",

journal = "Neoplasia",

issn = "1522-8002",

publisher = "Elsevier Inc.",

number = "12",

}

Chen, CW, Wu, MH, Chen, YF, Yen, TY, Lin, YW, Chao, SH, Tala, S, Tsai, TH, Su, TL & Lee, TC 2016, 'Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)', Neoplasia, 卷 18, 編號 12, 頁 808-809. https://doi.org/10.1016/j.neo.2016.10.005

TY - JOUR

T1 - Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)

AU - Chen, Chi Wei

AU - Wu, Ming Hsi

AU - Chen, Yi Fan

AU - Yen, Tsai Yi

AU - Lin, Yi Wen

AU - Chao, Shu Hsin

AU - Tala, Satishkumar

AU - Tsai, Tung Hu

AU - Su, Tsann Long

AU - Lee, Te Chang

PY - 2016

Y1 - 2016

N2 - The authors regret to have mistakenly placed the figure of body weight change in mice treated with different agents in PC9 cells (Figure 6A, right) with that of PC9/gef B4 cells (Figure 6B, right) during the art work. The corrected Figure 6 was attached below. The authors would like to apologize for any inconvenience caused.

AB - The authors regret to have mistakenly placed the figure of body weight change in mice treated with different agents in PC9 cells (Figure 6A, right) with that of PC9/gef B4 cells (Figure 6B, right) during the art work. The corrected Figure 6 was attached below. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85006175150&partnerID=8YFLogxK

U2 - 10.1016/j.neo.2016.10.005

DO - 10.1016/j.neo.2016.10.005

M3 - Comment/debate

AN - SCOPUS:85006175150

SN - 1522-8002

VL - 18

SP - 808

EP - 809

JO - Neoplasia

JF - Neoplasia

IS - 12

ER -

Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] (S1476558616000257)(10.1016/j.neo.2016.02.005)

摘要

UN SDG

存取文件

其它文件與鏈接

指紋

引用此